Pfizer starts phase-III clinical trial in adults for investigational vaccine against RSV EP News Bureau Sep 4, 2021 First subjects vaccinated in study of Pfizer’s RSV bivalent prefusion F subunit investigational vaccine candidate in adults aged…
